Analytical Method Development and Validation for Estimation of Vanoprazan in Pharmaceutical Dosage Forms Including Bioanalysis: A Comprehensive Literature Review
Year: 2025
Type: article
Abstract: Vanoprazan fumarate, a potassium-competitive acid blocker (PCAB), is a novel therapeutic agent for acid-related diseases. Accurate analytical methods for its quantification in pharmaceutical dosage forms and biological matrices are essential for quality control, formulation development, and pharmacokinetic studies. This review consolidates advances in analytical method development and validation for vanoprazan using UV-visible spectroscopy, high-performance liquid chromatography (HPLC), liquid chromatography-tandem mass spectrometry (LC-MS/MS), and other bioanalytical techniques. Validation according to ICH guidelines, method parameters, sample preparation, and applications are emphasized, providing a thorough overview of modern and classical methods.
Authors: N. Spandana, P. Pooja, Jutta Swathi, P.Vivek Sagar*
Institution: Vavuniya General Hospital
Language: English
Subfield: Analytical Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W7108336696
FWCI:
Cites:
Cited by:
Related to: